Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 28, 2026NeoplasiaOpen Access

PDLIM2 in lung adenocarcinoma metastasis

View Full Paper
Ask AI
Bookmark
Share

Authors

FGFeng GaoYXYadong XiaoHZHongqiao Zhang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gao et al. (2026) studied this question.

synapsesocial.com/papers/6ab9b5a47822ec8fc3d909eahttps://doi.org/10.1016/j.neo.2026.101371
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1PDLIM2 in Lung Adenocarcinoma Metastasis2025
  2. 2PDLIM2 acts as a central regulator of ubiquitination, immune signaling, and mitochondrial metabolism in lung cancer suppression (Review)2026
  3. 3Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma2026
  4. 4PDLIM2 expression and characteristics in KRAS- mutated lung adenocarcinoma.2026
  5. 5Tumor promoting effect of PDLIM2 downregulation involves mitochondrial ROS, oncometabolite accumulations and HIF-1α activation2024 · 8 citations